Taken together, CRABP2 was upregulated in HCC, which suggested a role for CRABP2 in the promotion of HCC growth and CRABP2 could serve as a new prognostic predictor for HCC, as well as a potential therapeutic target. Here, CRABP2 is linked to hepatocellular carcinoma.